A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis
NCT03089944
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
343
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis C Virus (HCV)
Interventions
DRUG:
Glecaprevir/Pibrentasvir
Sponsor
AbbVie